SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-005575
Filing Date
2018-04-20
Accepted
2018-04-20 17:29:55
Documents
7
Period of Report
2018-04-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 40715
2 ex4-1.htm EX-4.1 119526
3 ex4-2.htm EX-4.2 120693
4 ex5-1.htm EX-5.1 14759
5 ex10-1.htm EX-10.1 610640
6 ex99-1.htm EX-99.1 10063
7 image_001.jpg GRAPHIC 5214
  Complete submission text file 0001493152-18-005575.txt   924944
Mailing Address 860 N. ORANGE AVENUE SUITE B ORLANDO FL 32801
Business Address 860 N. ORANGE AVENUE SUITE B ORLANDO FL 32801 407-271-8516
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 18767605
SIC: 2836 Biological Products, (No Diagnostic Substances)